Prime Medicine, Inc. Common Stock Net Asset Quality Index
Prime Medicine, Inc. Common Stock net asset quality index. Prime Medicine, Inc. Common Stock (PRME) has a Net Asset Quality Index of 16.0% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $249.04 Million minus total liabilities of $209.23 Million yields net assets of $39.81 Million. A higher index indicates a stronger, lower-leverage balance sheet. See shareholders equity of Prime Medicine, Inc. Common Stock for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Prime Medicine, Inc. Common Stock (2019–2025)
Net asset quality index of Prime Medicine, Inc. Common Stock from 2019 to 2025. This chart shows how Prime Medicine, Inc. Common Stock's Net Asset Quality Index has evolved across 7 annual periods from 2019 to 2025. As of June 2026, the index stands at 16.0%, representing net assets of $39.81 Million against total assets of $249.04 Million USD. Check asset allocation strategy of Prime Medicine, Inc. Common Stock to assess the company's strategic physical and investment asset allocation.
Prime Medicine, Inc. Common Stock Net Asset Quality Index by Year (2019–2025)
Prime Medicine, Inc. Common Stock net asset quality index by year from 2019 to 2025. The table below presents the year-by-year Net Asset Quality Index for Prime Medicine, Inc. Common Stock from 2019 to 2025, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Prime Medicine, Inc. Common Stock market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 35.3% | $120.87 Million | $342.73 Million | $221.87 Million | ▼ -16.2 pp |
| 2024 | 51.5% | $153.15 Million | $297.51 Million | $144.36 Million | ▼ -17.2 pp |
| 2023 | 68.6% | $133.07 Million | $193.85 Million | $60.78 Million | ▼ -19.1 pp |
| 2022 | 87.8% | $316.27 Million | $360.31 Million | $44.04 Million | ▲ +8.4 pp |
| 2021 | 79.4% | $239.56 Million | $301.86 Million | $62.30 Million | ▲ +18.3 pp |
| 2020 | 61.1% | $33.47 Million | $54.78 Million | $21.31 Million | ▲ +45.1 pp |
| 2019 | 16.0% | $1.39 Million | $8.70 Million | $7.31 Million | — |